18,012 Shares in National Health Investors, Inc. $NHI Bought by Lazard Asset Management LLC

Lazard Asset Management LLC acquired a new position in National Health Investors, Inc. (NYSE:NHI) during the first quarter, Holdings Channel.com reports. The firm acquired 18,012 shares of the real estate investment trust’s stock, valued at approximately $1,456,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. International Assets Investment Management LLC acquired a new stake in shares of National Health Investors during the fourth quarter valued at about $27,000. EverSource Wealth Advisors LLC lifted its stake in shares of National Health Investors by 244.1% in the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after acquiring an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC purchased a new position in National Health Investors in the fourth quarter valued at about $33,000. Key Capital Management INC acquired a new stake in National Health Investors during the 4th quarter valued at approximately $47,000. Finally, Advisory Services Network LLC acquired a new stake in National Health Investors during the 3rd quarter valued at approximately $65,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Price Performance

Shares of NYSE NHI opened at $74.60 on Wednesday. National Health Investors, Inc. has a twelve month low of $67.94 and a twelve month high of $91.38. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83. The company has a market capitalization of $3.62 billion, a price-to-earnings ratio of 24.06, a price-to-earnings-growth ratio of 3.41 and a beta of 0.51. The business has a 50 day simple moving average of $75.09 and a 200-day simple moving average of $79.71.

Insiders Place Their Bets

In other National Health Investors news, CEO D. Eric Mendelsohn bought 1,500 shares of the company’s stock in a transaction on Friday, June 5th. The shares were bought at an average cost of $68.84 per share, with a total value of $103,260.00. Following the completion of the acquisition, the chief executive officer owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert A. Mccabe, Jr. purchased 890 shares of National Health Investors stock in a transaction dated Monday, June 15th. The stock was acquired at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the transaction, the director owned 44,159 shares in the company, valued at approximately $3,163,992.35. The trade was a 2.06% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 2.70% of the company’s stock.

Wall Street Analyst Weigh In

NHI has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft cut their target price on National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a research report on Thursday, June 25th. Truist Financial dropped their price target on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research note on Friday, June 12th. Zacks Research downgraded shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. Cantor Fitzgerald reissued an “overweight” rating and set a $94.00 price objective on shares of National Health Investors in a report on Wednesday, April 22nd. Finally, Wells Fargo & Company cut their target price on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a research note on Monday, June 1st. Five analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $83.86.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.